165 related articles for article (PubMed ID: 34646092)
1. p53-Induced Autophagy Regulates Chemotherapy and Radiotherapy Resistance in Multidrug Resistance Cancer Cells.
Ma S; Kong D; Fu X; Liu L; Liu Y; Xue C; Tian Z; Li L; Liu X
Dose Response; 2021; 19(4):15593258211048046. PubMed ID: 34646092
[TBL] [Abstract][Full Text] [Related]
2. The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells.
Kong D; Ma S; Liang B; Yi H; Zhao Y; Xin R; Cui L; Jia L; Liu X; Liu X
Biomed Pharmacother; 2012 Jun; 66(4):271-8. PubMed ID: 22564245
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of autophagy sensitizes MDR-phenotype ovarian cancer SKVCR cells to chemotherapy.
Liang B; Liu X; Liu Y; Kong D; Liu X; Zhong R; Ma S
Biomed Pharmacother; 2016 Aug; 82():98-105. PubMed ID: 27470344
[TBL] [Abstract][Full Text] [Related]
4. Autophagy inhibition plays the synergetic killing roles with radiation in the multi-drug resistant SKVCR ovarian cancer cells.
Liang B; Kong D; Liu Y; Liang N; He M; Ma S; Liu X
Radiat Oncol; 2012 Dec; 7():213. PubMed ID: 23244773
[TBL] [Abstract][Full Text] [Related]
5. P53 protein expression in human multidrug-resistant CEM lymphoblasts.
Rafki N; Liautaud-Roger F; Devy L; Trentesaux C; Dufer J
Leuk Res; 1997 Feb; 21(2):147-52. PubMed ID: 9112432
[TBL] [Abstract][Full Text] [Related]
6. Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines.
Hu XF; Martin TJ; Bell DR; de Luise M; Zalcberg JR
Cancer Res; 1990 May; 50(10):2953-7. PubMed ID: 2334897
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of chemosensitivity in multidrug-resistant human leukemia CEM cells by inhibition of DNA-dependent protein kinase using wortmannin.
Kim SH; Um JH; Dong-Won B; Kwon BH; Kim DW; Chung BS; Kang CD
Leuk Res; 2000 Nov; 24(11):917-25. PubMed ID: 11086175
[TBL] [Abstract][Full Text] [Related]
8. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells.
Weerasinghe P; Hallock S; Tang SC; Trump B; Liepins A
Exp Toxicol Pathol; 2006 Aug; 58(1):21-30. PubMed ID: 16735106
[TBL] [Abstract][Full Text] [Related]
9. Study of sodium orthovanadate as a reverser of multidrug resistance on lymphoblastic leukemic CEM/VLB100 cells.
Colin M; Madoulet C; Baccard N; Arsac F; Jardillier JC
Anticancer Res; 1994; 14(6A):2383-7. PubMed ID: 7825977
[TBL] [Abstract][Full Text] [Related]
10. Nuclear DNA content and chromatin texture in multidrug-resistant human leukemic cell lines.
Dufer J; Millot-Broglio C; Oum'Hamed Z; Liautaud-Roger F; Joly P; Desplaces A; Jardillier JC
Int J Cancer; 1995 Jan; 60(1):108-14. PubMed ID: 7814142
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
Wang Q; Beck WT
Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
[TBL] [Abstract][Full Text] [Related]
12. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.
Efferth T; Davey M; Olbrich A; Rücker G; Gebhart E; Davey R
Blood Cells Mol Dis; 2002; 28(2):160-8. PubMed ID: 12064912
[TBL] [Abstract][Full Text] [Related]
13. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
Beck WT; Cirtain MC; Lefko JL
Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
Hill AB; Beck WT; Trent JM
Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of Annona glabra plant extracts in human leukemia cell lines.
Cochrane CB; Nair PK; Melnick SJ; Resek AP; Ramachandran C
Anticancer Res; 2008; 28(2A):965-71. PubMed ID: 18507043
[TBL] [Abstract][Full Text] [Related]
16. Alterations of vinblastine influx in multidrug-resistant lymphoblastic leukaemic CEM cells.
Colin M; Madoulet C; Warren L; Jardillier JC
Anticancer Res; 1996; 16(1):407-12. PubMed ID: 8615645
[TBL] [Abstract][Full Text] [Related]
17. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
18. Radiation resistance in a multidrug resistant human T-cell leukemia line.
Shimm DS; Olson S; Hill AB
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):931-6. PubMed ID: 3182332
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients.
Soudon J; Berlion M; Lucas C; Haddad P; Bizzari JP; Calvo F
Cancer Chemother Pharmacol; 1995; 36(3):195-203. PubMed ID: 7781138
[TBL] [Abstract][Full Text] [Related]
20. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells.
Morgan SE; Kim R; Wang PC; Bhat UG; Kusumoto H; Lu T; Beck WT
Oncogene; 2000 Oct; 19(43):5010-9. PubMed ID: 11042688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
